EP2948148
Aðferðir til að meðhöndla sjálfsofnæmis-, öndunar- og bólguvaldandi raskanir með innöndun róflúmílast N-oxíðs
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
28.1.2014EP published:
29.7.2020EP application number:
14705875.4
EP translation filed:
27.10.2020Grant published:
15.11.2020EPO information:
European Patent Register
Max expiry date:
27.1.2034Expiry date:
27.1.2023
Title:
METHODS OF TREATING AUTOIMMUNE, RESPIRATORY AND INFLAMMATORY DISORDERS BY INHALATION OF ROFLUMILAST N-OXIDE
Timeline
Today
28.1.2014EP application
29.7.2020EP Publication
27.10.2020Translation submitted
15.11.2020Registration published
27.1.2023Expires
Owner
Name:
Incozen Therapeutics Pvt. Ltd.Address:
450, Alexandria Knowledge Park, Phase I Shameerpet, Hyderabad 500 078, IN
Inventor
Name:
VAKKALANKA, Swaroop KumarAddress:
Shameerpet Hyderabad 500078, IN
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
354CH2013Date:
28.1.2013Country:
IN
Number:
355CH2013Date:
28.1.2013Country:
IN
Classification
Categories:
A61K 31/44, A61K 45/06, A61P 11/00, A61P 29/00, A61P 37/00, A61K 9/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 19.1.2021
Expires: 27.1.2022
Payer: Patice ehf.
Number: 9
Paid: 21.1.2022
Expires: 27.1.2023
Payer: The International Renewals Group Inc.